期刊文献+

轻度认知障碍患者淋巴细胞蛋白磷酸酯酶-2A的变化

Changes of protein phosphotase-2A in lymphocytes of mild cognitive impairment patient
下载PDF
导出
摘要 【目的】探讨轻度认知功能障碍(mild cognitive impairment,MCI)患者淋巴细胞蛋白磷酸酯酶-2A(protein phosphotase-2 A,PP-2 A)的变化。【方法】用32P放射性标记法检测了PP-2 A的活性,并用免疫印迹法检测不同病程MCI患者及正常对照组血淋巴细胞PP-2 A的表达。【结果】1年MCI患者淋巴细胞PP-2 A的活性(0.91±0.06)与对照组(1.02±0.08)比较有降低(P<0.05),2年MCI(0.83±0.07)和3年MCI(0.85±0.07)患者淋巴细胞PP-2 A的活性与对照组比较有明显降低(P<0.01,P<0.01),与1年MCI的比较虽有降低的趋势,但无统计学意义(P>0.05)。1年MCI组淋巴细胞PP-2 A的表达(0.95±0.06)与对照组(1.01±0.07)比较无明显降低(P>0.05),而2年MCI组(0.85±0.07)及3年MCI组(0.86±0.06)的PP-2 A表达与对照组相比明显降低(P<0.01,P<0.01),1年MCI组与2年MCI组的PP-2 A的表达无明显差别(P>0.05),与3年MCI组也无差别(P>0.05)。【结论】MCI患者淋巴细胞PP-2 A的活性及表达降低,对MCI的诊断可能有参考价值。 [ Objective] To explore the alterations of PP- 2 A in lymphocytes in patients with mild cognitive impairment. [Methods] The activity of PP- 2 A was determined by 32 p-labelled in control group, 1 - year MCI group, 2 - year MCI group and 3 - year MCI group, and the expression of PP - 2 A was measured by Westernblot in these groups too. [ Results] The activity of PP - 2 A was decreased in 1 - year MCI group (0.91 ± 0.06) as compared with controls ( 1.02 ± 0.08) ( P 〈 0.05). A lower decrease of PP- 2 A activity was also induced in 2 - year MCI group (0.83 ± 0.07) and 3 - year MCI group (0.85 ± 0.07) as compared with controls (P〈0.01, P〈0.01)o There was no obvious difference among the three MCI groups (P 〉 0.05). In other hand, the expression of PP-2 A was not slgnificandy lower in 1- year MCI group (0.95 ±0.06) as compared with control group (1.01 ± 0.07), but the expression of PP - 2 A in 2 - year MCI group (0.85 ± 0.07) and 3 - year MCI group (0.86 ±0.06) was lower as compared with control group ( P 〈 0.01, P 〈 0.01). There was no obvious difference between 1 - year MCI group and 2 - year MCI group ( P 〉 0.05), and no obvious difference was induced between 1 - year MCI group and 3 - year MCI group ( P 〉 0.05). [ Conclusions] Lower expression and activity of PP- 2 A in lymphocytes implies a possible value of MCI diagnosis.
出处 《武警医学院学报》 CAS 2008年第11期944-946,共3页 Acta Academiae Medicinae CPAPF
基金 中国博士后基金资助项目(20060390635)
关键词 轻度认知障碍 淋巴细胞 蛋白磷酸酯酶-2 A Mild cognitive impairment Lymphocyte Protein phosphotase - 2 A
  • 相关文献

参考文献9

  • 1Honsson O, Zetterberg H, Buehhave P, et al. Association between GSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study[J].Lancet Neurol,2006,5(3): 228 - 234.
  • 2Iqbal K, Grundke-Iqbal I. Pharmacological approaches of neurofibrillary degeneration [ J]. Curr Alzheimer Res, 2005, 2(3) : 335 - 341.
  • 3Albrecht S, Bourdeau M, Bennett D, et al. Activation of caspase - 6 in aging and mild cognitive impairment [J]. Am J Pathol, 2007, 170 (4) : 1200 - 1209.
  • 4Hye A, Kerr F, Archer N, et al. Glycogen synthase kinase- 3 is increased in white cells early in Alzheimer's disease [J]. Neurosci Lett, 2005(1), 373: 1-4.
  • 5Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment [J]. Arch Neurol, 2001, 58(12): 1985- 1992.
  • 6Gitmta M, Rigamonti AE, Scarpini E, et al.The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment [J]. Neurobiol Aging, 2007, 28(4): 515-518.
  • 7薛志强,李春波,吴文源.老年轻度认知功能损害的研究进展[J].中国行为医学科学,2006,15(5):475-476. 被引量:9
  • 8Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer's disease[J].Clin Neurol Neurosurg, 2005, 107(3) : 165- 173.
  • 9Pei JJ, Gong CX, Iqbal K, et al. Subcellular distribution of protein phosphatases and abnormally phosphorylated tan in the temporal cortex from Alzheimer's disease and control brains [J]. J Neural Transm, 1998, 105(1): 69-83.

二级参考文献23

  • 1赵光远,李秀艳,王玉良.壳聚糖磷脂复合物对老年认知功能的影响[J].中国行为医学科学,2005,14(1):58-59. 被引量:2
  • 2Petersen RC,Smith GE,Waring SC,et al.Mild cognitive impairment:clinical characterization and outcome.Archives of Neurology,1999,56:303-308.
  • 3Pertersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive impairment.Archneurol,2001,58:1985-1992.
  • 4Busse A,Jeannette B,Steffi G,et al.Mild cognitive impairment:prevalence and incidence accoring to different diagnostic criteria.Br J Psychiatry,2003,182:449-454.
  • 5Dorene MR,Terri JH,Robert RF,et al.Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals.Neuropsychology,2004,18:138-149.
  • 6Hlne A,Luc L,Jean-Franois D,et al.Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.Dement Geriatr Cogn Disord,2004,18:87-93.
  • 7Inge CK,Jocelyne DR,Annie G,et al.The role of cognitive stimulation in diagnosing mild-cognitive-impairment subjects at risk for Alzheimertype dementia.Brain Aging,2002,2:4.
  • 8Larrieu S,Letenneur L,Orgogozo JM et al.Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.Neurology,2002,59:1594-1599.
  • 9Deloen MJ,Desanti S,Zinkowski R,et al.MRI and CSF studies in the early diagnosis of Alzheimer's disease.Journal of Internal Medicine,2004,256:205-223.
  • 10Kantarci K,Jack CR,Xu YC,et al.Regional metabolic patterns in mild cognitive and Alzheimer 's disease:AIH MRS study.Neurology,2000,55:210-217.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部